Therapy for Multiple Myeloma - Quo Vadis?

Abstract

Two major developments are changing our current understanding of cancer: (1) the in-depth analysis of tumour-harbouring mutations and (2) the generation of highly active T cell-involving immunotherapies. In this editorial, we focus on its impact on myeloma therapy and speculate on future treatment concepts.